CHESTERBROOK, PA — Trevena, Inc. (NASDAQ: TRVN) announced the recent additions of three key members to its leadership team. The Company has appointed Linda Wase, M.D. as Vice President of Medical Affairs, Michael Catalano as Vice President of Marketing, and Bob Yoder as Vice President of Sales & Commercial Operations.
Linda Wase, M.D., has worked with Trevena since 2017, first as a consultant guiding Medical Affairs strategy and, since March 2018, as Vice President of Medical Affairs. She has over 30 years of industry experience and has held multiple senior-level roles in Clinical Development and Medical Affairs, working at GlaxoSmithKline, Archimedes Pharma, King Pharmaceuticals, Bristol-Meyers Squibb, and Lederle Laboratories, among others. Dr. Wase is board certified in Internal Medicine.
Michael Catalano joined Trevena as Vice President of Marketing in February of this year. He brings a wealth of experience from Merck in US and global marketing, corporate licensing, and business development across oncology, vaccines, pain, and acute care/hospital. Mr. Catalano is also a licensed pharmacist in Pennsylvania.
Bob Yoder has joined Trevena as Vice President of Sales & Commercial Operations. He brings over 20 years of pharmaceutical industry experience in sales operations, sales, and business planning. After holding various commercial roles at Merck, Mr. Yoder was Senior Vice President & Head of Global Commercial Operations, Alliance Management & IT at Orexigen.
“We are excited to add three talented individuals to our team,” said Maxine Gowen, President & CEO. “Linda, Michael, and Bob each bring considerable industry experience and will play an instrumental role in advancing oliceridine and our other investigational products to help patients in need.”
Source: Trevena, Inc., 955 Chesterbrook Blvd, Suite 200, Chesterbrook PA 19087
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.